Her-2 Expression in Gastroesophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma.

Authors:
Almhanna K; Rosa M; Henderson-Jackson E; Jiang K; Shamekh R and 3 more

Journal:
Appl Immunohistochem Mol Morphol

Publication Year: 2016

DOI:
10.1097/PAI.0000000000000243

PMCID:
PMC7771552

PMID:
26186253

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Appl Immunohistochem Mol Morphol

Abbreviation: Appl Immunohistochem Mol Morphol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Histocytochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Belgian Recommendations for Analytical Verification and Validation of Immunohistochemical Tests in …
Verbeke H; Van Hecke D; Bauraing C and 9 more (2023) - Transparency Score: 2/6
Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich…
Zhao Y; Huang T; Jin X and 2 more (2023) - Transparency Score: 3/6
Depigmentation of Melanin-containing Tissues Using Hypochlorous Acid to Enhance Hematoxylin-eosin a…
Wang L; Wang G. (2023) - Transparency Score: 2/6
Effect of Surface Decalcification With Hydrochloric Acid on the Determination of Estrogen Receptor,…
Ping W; Xin R; Li Z and 5 more (2023) - Transparency Score: 3/6
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer.
Weidemann S; Gorbokon N; Lennartz M and 20 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare no conflict of interest."

Evidence found in paper:

"Supported by Genentech."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025